Lumipulse® sTREM2 Controls
These controls are intended for use as an assayed quality control to monitor the precision and accuracy of laboratory testing procedures for the analysis of soluble triggering receptor expressed on myeloid cells 2 (sTREM2) in human serum, plasma and cerebrospinal fluid (CSF) on the automated LUMIPULSE® G System.
This product is not for use in diagnostic procedures, for ‘Research Use Only’.
Product # 81658
Click here to navigate
- Contact sales for information
- Documentation
- Insights
- Product inquiry
- Related products
-
Documentation
Browse regulatory documents for this product
Create a free membership account and start browsing all product documentation right away.
Get access to this section and more
Create a membership account to review and download product-specific documentation.
-
Insights
Sep 25, 2025How Can You Diagnose Alzheimer's at the Earliest Stages?
Diagnosing Alzheimer’s at the Earliest Stages
An early Alzheimer’s diagnosis has never been more important — or more attainable — than it is today...
Aug 27, 2025The Future of Alzheimer's Disease Diagnosis
What is the future of Alzheimer's disease diagnosis?
Two anti-amyloid drugs are now available to patients with mild cognitive impairment (MCI) or mild...
Jun 25, 2025Everything You Need to Know About Amyloid Presence and Alzheimer’s Disease-modifying Therapies
Confirming amyloid pathology before administering Alzheimer’s disease-modifying therapies.
Approximately seven million Americans are currently living...
-
Product inquiry